iqvia semaglutide tirzepatide prescriptions q3 2024 GLP-1 RA prescription trends: January 2018 – December Newer Weight-Loss Drugs Not Cost-effective

Third-line ITC: Overall, semaglutide tablets were found to be the most efficacious for reducing A1C versus all other third-line treatments

Zepbound is indicated if: You are obese (body mass index (BMI) of 30 or more) or, Overweight (BMI 27 or more) and you have at least one weight-related condition, such as diabetes, hypertension (high blood pressure), hypercholesterolemia, or heart disease, or, You have moderate to severe obstructive sleep apnea (OSA) due to obesity You can get a Mounjaro prescription if you have type 2 diabetes

Where should you inject Mounjaro for best results

The supply situation has stabilized as of 2025 but isnt guaranteed

The profile is broadly comparable to, though not identical to, the side effect profiles of semaglutide and tirzepatide